Abbott Laboratories buy JPMorgan Chase & Co.
Start price
17.04.26
/
50%
€80.40
Target price
17.04.27
€93.41
Performance (%)
-1.22%
Price
18:04
€79.42
Summary
This prediction is currently active. With a performance of -1.22%, the BUY prediction for Abbott Laboratories by JPMorgan_Chase___Co_ is down slightly. This prediction currently runs until 17.04.27. The prediction end date can be changed by JPMorgan_Chase___Co_ at any time. JPMorgan_Chase___Co_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Abbott Laboratories | 0.392% | 0.392% |
| iShares Core DAX® | 0.878% | 1.051% |
| iShares Nasdaq 100 | 0.753% | 4.664% |
| iShares Nikkei 225® | 5.519% | 15.411% |
| iShares S&P 500 | 0.236% | 1.683% |
Comments by JPMorgan_Chase___Co_ for this prediction
In the thread Discuss Abbott Laboratories
Abbott Laboratories (ABT) had its price target lowered by JPMorgan Chase & Co. from $123.00 to $110.00. They now have an "overweight" rating on the stock.
Ratings data for ABT provided by MarketBeat
Stopped prediction by JPMorgan_Chase___Co_ for Abbott Laboratories
Abbott Laboratories
Start price
Target price
Perf. (%)
€101.24
20.04.23
20.04.23
€111.01
20.04.24
20.04.24
-0.75%
21.04.24
21.04.24
